Provided by Tiger Trade Technology Pte. Ltd.

Precision Biosciences Inc

5.06
-0.2900-5.42%
Pre-market: 5.650.5900+11.66%07:12 EDT
Volume:236.09K
Turnover:1.19M
Market Cap:121.80M
PE:-0.61
High:5.35
Open:5.33
Low:4.81
Close:5.35
52wk High:8.82
52wk Low:3.53
Shares:24.07M
Float Shares:22.82M
Volume Ratio:0.79
T/O Rate:1.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.3225
EPS(LYR):1.04
ROE:-205.16%
ROA:-45.34%
PB:7.32
PE(LYR):4.87

Loading ...

Precision BioSciences Reports Positive Phase 1 Results for Gene Editing Therapy in Chronic Hepatitis B

Reuters
·
Nov 11, 2025

Precision BioSciences trading halted, news pending

TIPRANKS
·
Nov 11, 2025

Precision BioSciences Q3 revenue falls sharply

Reuters
·
Nov 03, 2025

Precision BioSciences reports third quarter 2025 revenue of less than $0.1 million and research and development expenses of $13.4 million

Reuters
·
Nov 03, 2025

Precision BioSciences Q3 EPS $(1.84) Misses $(1.34) Estimate, Sales $13.000K Miss $5.400M Estimate

Benzinga
·
Nov 03, 2025

BRIEF-Precision BioSciences, Inc. Q3 Revenue USD 13 Thousand

Reuters
·
Nov 03, 2025

Precision BioSciences Inc - Ind Filing for Pbgene-Dmd Expected by End of 2025

THOMSON REUTERS
·
Nov 03, 2025

Precision BioSciences Inc - Expected Cash Runway Into Second Half of 2027

THOMSON REUTERS
·
Nov 03, 2025

Precision BioSciences, Inc. Q3 Income From Operations USD -20.667 Million

THOMSON REUTERS
·
Nov 03, 2025

Precision BioSciences Inc Q3 Shr View $-1.34 -- Lseg Ibes Data

THOMSON REUTERS
·
Nov 03, 2025

Precision BioSciences Inc expected to post a loss of $1.34 a share - Earnings Preview

Reuters
·
Oct 31, 2025

Press Release: Precision BioSciences to Report Third Quarter 2025 Financial Results on November 3, 2025

Dow Jones
·
Oct 31, 2025

H.C. Wainwright Remains a Buy on Precision BioSciences (DTIL)

TIPRANKS
·
Oct 28, 2025

H.C. Wainwright Sticks to Its Buy Rating for Precision BioSciences (DTIL)

TIPRANKS
·
Oct 15, 2025

Precision BioSciences to Present Positive Phase 1 PBGENE-HBV Gene Editing Data at 2025 AASLD Liver Meeting

Reuters
·
Oct 14, 2025

Precision BioSciences Announces Late-Breaking Oral Presentation for Pbgene-Hbv at Aasld the Liver Meeting® 2025

THOMSON REUTERS
·
Oct 14, 2025

Precision BioSciences publishes ARCUS nucleases data

TIPRANKS
·
Oct 09, 2025

Precision BioSciences reveals ARCUS nuclease enables high efficiency gene insertion in dividing and nondividing cells

Reuters
·
Oct 09, 2025

Precision BioSciences Announces Opening of First Clinical Trial Site in U.S. for Eliminate-B Trial

THOMSON REUTERS
·
Oct 07, 2025

Precision BioSciences announces presentation at WMS on PBGENE-DMD

TIPRANKS
·
Sep 30, 2025